Compare Etsy Inc (ETSY) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Pfizer Inc — how do they compare? Etsy Inc trades at $74.76 (market cap $6.90B), while Pfizer Inc trades at $27.83 (market cap $159.59B). The key difference: Pfizer Inc is far larger — about 23.1× Etsy Inc's market cap, and Pfizer Inc pays a 6.14% dividend while Etsy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Pfizer Inc for 158 Days on average.
| ETSY | PFE | |
|---|---|---|
Market Cap | $6.90B | $159.59B |
Volume | 2,923,867 | 30,937,010 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $29.02 |
52-Week Low | $44.05 | $23.67 |
Typical Hold Time | 67 Days | 158 Days |
Enterprise Value | $8.85B | $211.09B |
Dividend Yield | — | 6.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $71.49, up 0.14% with a bearish technical signal despite recent earnings beats. The company shows strong gross margins of 71.4% but faces profitability challenges with negative ROE of -1,224.5%. Recent news highlights AI integration initiatives and payment partnership renewals, while analyst consensus remains bullish with a $85.94 price target representing 20% upside potential.
ETSY presents a mixed investment case with solid revenue growth and strong analyst support offset by weak profitability metrics and technical headwinds. The stock's 20% discount to consensus target offers potential upside, but investors must weigh competitive pressures in e-commerce against the company's unique marketplace positioning and AI-driven growth initiatives.
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
